Legal & General Group
MBX

Legal & General Group’s MBX Biosciences MBX Stock Holding History

Legal & General Group’s Portfolio MBX Stock Details MBX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$578K Buy
19,358
+16,819
+662% +$572K ﹤0.01% 2320
2025
Q4 		$80.1K Buy
2,539
+1,211
+91% +$29.4K ﹤0.01% 2657
2025
Q3 		$23.2K Sell
1,328
-223
-14% -$2.98K ﹤0.01% 2981
2025
Q2 		$17.7K Buy
1,551
+444
+40% +$4.52K ﹤0.01% 3061
2025
Q1 		$8.17K Hold
1,107
– – ﹤0.01% 3213
2024
Q4 		$20.4K Sell
1,107
-3,893
-78% -$83K ﹤0.01% 3012
2024
Q3 		$128K Buy
+5,000
New +$114K ﹤0.01% 2714

Other funds holding MBX

FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
NA
NVP Associates Menlo Park, California $176M AUM 208.78% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $28.2B AUM 115.26% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return

Legal & General Group's MBX Position: Q1 2026 in Review

Legal & General Group increased its MBX Biosciences (MBX) stake by 662% in Q1 2026, buying an estimated $572K and bringing the position to 19,358 shares worth $578K. The position accounts for ﹤0.01% of the portfolio, ranked #2320.

Legal & General Group first reported a position in MBX in Q3 2024 and has held it in 7 quarters since. 157 funds tracked by Wall St. Rank hold MBX as of Q1 2026.

  • Legal & General Group held 19,358 shares of MBX Biosciences worth $578K as of Q1 2026.
  • Legal & General Group bought 16,819 MBX Biosciences shares in Q1 2026, an estimated $572K.
  • MBX Biosciences made up ﹤0.01% of Legal & General Group's portfolio in Q1 2026, its #2320 holding.
  • Legal & General Group first reported a position in MBX Biosciences in Q3 2024 and has held it in 7 quarters since.
  • 157 funds tracked by Wall St. Rank held MBX Biosciences as of Q1 2026.

Based on Legal & General Group's 13F filing for Q1 2026, filed 8 May 2026.